Regulatory & evidence callout: DSIP is investigational, research-only, and not FDA-approved
glibenclamide), this may represent a further mechanism of action
This caution is based on findings from animal studies and limited human case reports
This could involve temporarily reducing the dose, switching to a different GLP-1 receptor agonist with a different pharmacokinetic profile, or investigating whether concurrent medications contribute to tiredness
Gut Health and Digestive Support BPC-157 has been shown to help with digestive disorders, including ulcers, leaky gut syndrome, and irritable bowel syndrome
If your levels are high, then focus on low iodine foods